News

Aphria to commence trading on the NYSE on November 2

October 30, 2018

Aphria Commends UK Government on Medical Cannabis Legalization, Forms Alliance with Neurologist and Leading Cannabis Advocate Professor Michael Barnes

October 16, 2018

Aphria completes first shipment of cannabis oil to Argentina for clinical study on treating refractory epilepsy in children

October 15, 2018

Aphria Signs Wholesale Supply Agreement With Emblem Cannabis Corporation

September 12, 2018

Aphria Signs Wholesale Supply Agreement With Emblem Cannabis Corporation

September 12, 2018

Aphria Records Revenue Increase of 17% in Quarter and 81% Year Over Year

August 1, 2018

Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria

July 17, 2018

Aphria Announces Closing of Bought Deal Financing

June 28, 2018

Breakout Alert: Aphria Inc Poised To Move Significantly Higher

June 22, 2018

Aphria’s Malta-based subsidiary, ASG Pharma, receives first import license for cannabis issued by the Malta Medicines Authority

June 21, 2018